This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Löfqvist, C. Articles by Wikland, K. A. Search for Related Content PubMed PubMed Citation Articles by Löfqvist, C. Articles by Wikland, K. A.

Reference Values for IGF-I throughout Childhood and Adolescence: A Model that Accounts Simultaneously for the Effect of Gender, Age, and Puberty

Göteborg Pediatric Growth Research Center (C.L., L.G., S.R., K.A.W.), Institute for the Health of Women and Children and Department of Statistics (E.A.), The Sahlgrenska Academy at Göteborg University, S-416 85 Göteborg, Sweden; and University of Giessen and Lilly Research Laboratories (W.F.B.), D-35 385 Bad Homburg, Germany

Address all correspondence and requests for reprints to: Chatarina Löfqvist, University of Göteborg, Institute for the Health of Women and Children, Göteborg Pediatric Growth Research Center, The Queen Silvia Children’s Hospital, S-416 85 Göteborg, Sweden. E-mail: chatarina.lofqvist{at}vgregion.se

Abstract

We have constructed a reference model to facilitate comparison of serum IGF-I values among children, and thereby to improve the value of IGF-I measurements for diagnosis. The data set consists of serum values measured in 969 samples from 468 healthy children and adolescents (232 males, 236 females; ages, 1.1–18.3 yr). One sample per child was used for the model, each being selected so as to provide sufficient observations for each stage of puberty. The samples not selected were used to validate the reference data. The IGF-I values were log transformed, and multiple regression analysis was used in the model-building process. The best linear model, which converts serum IGF-I concentrations into SD scores and explains 66% of the variation in logIGF-I values, includes the variables of age, gender, and puberty, and takes the interactions among these variables into account. In prepubertal and early pubertal children, the relationship between age and logIGF-I was positive, with greater effect in girls older than 8 yr. In mid-puberty, logIGF-I values were higher in girls than in boys of the same age, up to 16 yr of age. Among boys, the most pronounced positive relationship between age and logIGF-I occurred in mid-puberty, whereas the relationship between age and logIGF-I among girls in mid-puberty is fairly constant. In late puberty, logIGF-I values were higher than earlier in puberty, and there was a negative relationship with age in both boys and girls. Instead of separate models for each combination of puberty and gender, estimating a single regression model permits simultaneous estimation of all explanatory variables and uses all observations in the data set, thereby making it easier to select those variables that have a significant effect on logIGF-I. Our model shows that IGF-I levels are related to age during each stage of puberty. The model also accounts for the fact that serum IGF-I concentrations during puberty are different for boys and girls.

This article has been cited by other articles:

				K. Albertsson-Wikland, A. S. Aronson, J. Gustafsson, L. Hagenas, S. A. Ivarsson, B. Jonsson, B. Kristrom, C. Marcus, K. O. Nilsson, E. M. Ritzen, et al. Dose-Dependent Effect of Growth Hormone on Final Height in Children with Short Stature without Growth Hormone Deficiency J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4342 - 4350. [Abstract] [Full Text] [PDF]

				J. Leger, I. Mercat, C. Alberti, D. Chevenne, P. Armoogum, J. Tichet, and P. Czernichow The relationship between the GH/IGF-I axis and serum markers of bone turnover metabolism in healthy children Eur. J. Endocrinol., November 1, 2007; 157(5): 685 - 692. [Abstract] [Full Text] [PDF]

				P.-M. Holterhus, R. Odendahl, S. Oesingmann, R. Lepler, V. Wagner, O. Hiort, R. Holl, and the German/Austrian DPV Initiative and the German Classification of Distinct Baseline Insulin Infusion Patterns in Children and Adolescents With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy Diabetes Care, March 1, 2007; 30(3): 568 - 573. [Abstract] [Full Text] [PDF]

				A. B. Loucks The Response of Luteinizing Hormone Pulsatility to 5 Days of Low Energy Availability Disappears by 14 Years of Gynecological Age J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3158 - 3164. [Abstract] [Full Text] [PDF]

				R. Verkauskiene, D. Jaquet, S. Deghmoun, D. Chevenne, P. Czernichow, and C. Levy-Marchal Smallness for Gestational Age Is Associated with Persistent Change in Insulin-Like Growth Factor I (IGF-I) and the Ratio of IGF-I/IGF-Binding Protein-3 in Adulthood J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5672 - 5676. [Abstract] [Full Text] [PDF]

				Y. H. Choe, S. Y. Song, K.-H. Paik, Y. J. Oh, S.-H. Chu, S. H. Yeo, E. K. Kwon, E. M. Kim, M. Y. Rha, and D.-K. Jin Increased Density of Ghrelin-Expressing Cells in the Gastric Fundus and Body in Prader-Willi Syndrome J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5441 - 5445. [Abstract] [Full Text] [PDF]

				S. Tenhola, P. Halonen, J. Jaaskelainen, and R. Voutilainen Serum markers of GH and insulin action in 12-year-old children born small for gestational age Eur. J. Endocrinol., March 1, 2005; 152(3): 335 - 340. [Abstract] [Full Text] [PDF]

				C. Lofqvist, E. Andersson, L. Gelander, S. Rosberg, L. Hulthen, W. F. Blum, and K. A. Wikland Reference Values for Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) and the Ratio of Insulin-Like Growth Factor-I to IGFBP-3 throughout Childhood and Adolescence J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1420 - 1427. [Abstract] [Full Text] [PDF]

				T. Saukkonen, R. Amin, R. M. Williams, C. Fox, K. C. Yuen, M. A. White, A. M. Umpleby, C. L. Acerini, and D. B. Dunger Dose-Dependent Effects of Recombinant Human Insulin-Like Growth Factor (IGF)-I/IGF Binding Protein-3 Complex on Overnight Growth Hormone Secretion and Insulin Sensitivity in Type 1 Diabetes J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4634 - 4641. [Abstract] [Full Text] [PDF]

				L. B. Johnston, J. Dahlgren, J. Leger, L. Gelander, M. O. Savage, P. Czernichow, K. A. Wikland, and A. J. L. Clark Association between Insulin-Like Growth Factor I (IGF-I) Polymorphisms, Circulating IGF-I, and Pre- and Postnatal Growth in Two European Small for Gestational Age Populations J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4805 - 4810. [Abstract] [Full Text] [PDF]

				J. C. Bunt, A. D. Salbe, M. H. Tschop, A. DelParigi, P. Daychild, and P. A. Tataranni Cross-Sectional and Prospective Relationships of Fasting Plasma Ghrelin Concentrations with Anthropometric Measures in Pima Indian Children J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3756 - 3761. [Abstract] [Full Text] [PDF]

				N. Stefan, J. C. Bunt, A. D. Salbe, T. Funahashi, Y. Matsuzawa, and P. A. Tataranni Plasma Adiponectin Concentrations in Children: Relationships with Obesity and Insulinemia J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4652 - 4656. [Abstract] [Full Text] [PDF]